Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Effectiveness, safety, and factors associated with the clinical success of endoscopic biliary drainage for patients with hepatocellular carcinoma: a retrospective multicenter study

Fig. 3

The median survival duration was significantly longer in patients with HCC treatment after ERCP than in those without treatment (12 months vs. 2.8 months; HR 4.3, 95% CI 4.93–21.5). Among patients without HCC treatment after ERCP, the median survival duration was significantly longer in patients with clinical success than in those with clinical failure (3.8 months vs. 0.73 months; HR 2.1, 95% CI 2.8–5.7)

Back to article page